Washington — As Senate Democrats work to push through President Biden’s remaining nominees to the nation’s courts before he leaves office and control of the upper chamber flips, they are bumping up against efforts by their Republican colleagues to slow down the pace of confirmations, amid President-elect Donald Trump’s urging that his party “hold the line.”

Mr. Biden and Trump have made judicial nominations a priority in their respective terms in office, as courts become the arbiters of politically charged disputes over issues that affect all corners of American life.

During his first term in office, the Senate confirmed 234 of Trump’s judicial nominees to the Article III courts, which include the Supreme Court, federal appeals courts, district courts and U.S. Court of International Trade. But Mr. Biden is fast approaching that number for his four years in office, with the Senate approving 217 of his candidates for the federal bench so far. There are 44 current vacancies, and 14 nominees awaiting action by the upper chamber, according to the Judicial Conference.

Democrats are hoping to meet or surpass Trump’s 234 judicial confirmations during the lame-duck session, but have encountered resistance from Republicans — who, egged on by Trump — looking to hold up and drag out the process.

When the Senate convened for votes Monday, Republicans used procedural maneuvers to drag out the floor proceedings, slowing Democrats’ efforts to confirm Mr. Biden’s judicial picks. The plan to slow down the confirmations was orchestrated by Sen. John Thune of South Dakota, who was elected last week to serve as the next GOP leader, according to Fox News.

“If Sen. Schumer thought Senate Republicans would just roll over and allow him to quickly confirm multiple Biden-appointed judges to lifetime jobs in the final weeks of the Democrat majority, he thought wrong,” Thune said in a statement.

Trump is also pushing Senate Republicans to thwart Democrats’ efforts to continue approving Mr. Biden’s judicial picks.

“The Democrats are trying to stack the courts with radical left judges on their way out the door,” he wrote on social media. “Republican senators need to show up and hold the line — no more judges confirmed before inauguration day!”

But Democrats are not breaking new ground by confirming Mr. Biden’s judicial nominees during the lame-duck session. In 2020, after Trump lost his bid for reelection, the GOP-led Senate confirmed 19 candidates to the federal bench, including one judge to the U.S. Court of Appeals for the 7th Circuit and four to the U.S. Court of Federal Claims.

Among those who won approval in the weeks after the 2020 election was U.S. District Judge Kathryn Mizelle, who at 33 years old was the youngest of Trump’s nominees and was deemed “not qualified” to serve on the district court by the American Bar Association. U.S. District Judge Aileen Cannon, who tossed out the criminal case against Trump for his alleged mishandling of sensitive documents, was also confirmed by the Senate after the 2020 election.

“Delaying the confirmation of highly qualified, experienced judges takes a real-life toll on constituents and leads to backlogs of criminal cases – meaning Senator Thune was correct in 2020 when he said senators have every urgent reason to continue working together in good faith to staff the federal bench,” Andrew Bates, White House spokesperson, said of the efforts to gum-up the confirmation process. “There is no excuse for choosing partisanship over enforcing the rule of law.”

Advocacy groups are pressuring Senate Democrats to continue to hold votes to approve all of the president’s remaining nominees to the federal bench before Trump takes office in late January and Republicans claim the majority in the Senate.

On Friday, the Leadership Conference on Civil Rights and 141 groups sent a letter to senators urging them to confirm all pending judicial nominees, calling it “urgent and enduring.” 

“We implore you to stay in and do this necessary work,” the organizations said. “It is essential that we leave no judges behind.”

Demand Justice, a progressive judicial advocacy group, also launched a campaign aimed at pressuring senators to green-light Mr. Biden’s picks for the federal courts.

“With only weeks left before the new Congress, it’s more urgent than ever that Democratic senators do whatever it takes — staying late, working weekends — during the lame duck session to confirm the dozens of remaining fair-minded, qualified judges nominated by President Biden that the American people deserve,” said Maggie Jo Buchanan, managing director of Demand Justice.

Senate Democrats are unbowed by Republicans’ efforts and have indicated they will charge ahead with confirming Mr. Biden’s judicial picks.

Senate Majority Leader Chuck Schumer stressed Tuesday that Democrats “are not done yet,” and said his party will do what it can to “get as many judges confirmed as we can.” 

“Everyone should be prepared for another late night on Wednesday to vote on nominations and get as many judges done as possible,” the New York Democrat said, adding that Republicans “can try dilatory tactics but we’re going to persist, as we showed last night, as we’re persisting now.”

Sen. Dick Durbin, the Democratic whip who also chairs the Judiciary Committee, celebrated the judges brought forward by the committee over the last four years of Democratic control, noting that the vast majority of the judges that the Senate has considered are bipartisan, winning support from Republicans. 

But some Republicans didn’t see them that way, such as Sen. John Kennedy of Louisiana, who argued that many of Mr. Biden’s nominees “are not qualified to be on the federal bench” and called them “activists.” 

Still, Senate Republicans acknowledge that they can’t block the judicial picks across the board as Trump has requested. Sen. Pete Ricketts, a Nebraska Republican, said that although Republicans would like to deliver on Trump’s wishes, “Democrats are in the majority, and even if we have all of our members here, we still can’t prevent that, as long as they have all their members.”

“So, we’ll certainly try,” Ricketts said.

Nationwide rates of emergency room visits for babies with Mycoplasma pneumoniae are on track to surpass rates for school-age children, data from the U.S. Centers for Disease Control and Prevention shows, as doctors nationwide are grappling with a surge of “walking pneumonia” cases. 

The new figures come from the CDC’s National Syndromic Surveillance Program, which gathers data on pneumonia-associated emergency room visits from U.S. hospitals.

While cases had been higher in school-age kids compared to other age groups, rates in babies have surged in recent weeks, and are now tied with older kids. According to the latest CDC data, for the week ending Nov. 2, 7.6% of emergency department pneumonia cases for babies 0-1 years old and children ages 5-17 years old resulted in Mycoplasma pneumoniae diagnoses.

“These diagnoses dropped a little after August, but remained high through early November. Of note, diagnoses among 0–1-year-olds have steadily increased throughout the fall without any subsequent decrease,” CDC spokesperson Jasmine Reed said in a statement Tuesday.

During the COVID-19 pandemic, cases largely disappeared. CDC officials had said that this year’s wave could be heralding a return to waves of Mycoplasma pneumoniae cases that occurred prior to the pandemic. 

But this year’s trend has also been unusual, since cases had previously been thought to be common only in school-aged kids, not younger children.

“While we are seeing right now that it is presenting as a typical respiratory infection, we want to make sure that there isn’t something unusual going on with the bacteria itself or the way it’s showing up that might give guidance in how to treat and prevent it,” Dr. Adam Cohen, head of the CDC’s pneumonia branch, told Medscape News earlier this month. 

According to Reed, while every U.S. region is seeing an increase in Mycoplasma pneumoniae cases, the CDC’s data suggests that since at least last month — when several states first began to raise concerns over the surge — the ERs of three regions specifically are seeing the highest levels of the bacteria. 

One is in the South and spans Texas and its neighbors Arkansas, Louisiana, Oklahoma and New Mexico. The second is in the Midwest and includes Iowa, Kansas, Missouri and Nebraska. The third is in the Northeast and includes New York and New Jersey. 

“Maybe it’s another one of those things that we didn’t see, got really suppressed during COVID, and now it’s coming back,” said Dr. Jennifer Nayak, division chief of pediatric infectious disease at Golisano Children’s Hospital in New York. “It just is definitely a really bad year for Mycoplasma.” 

Nayak said that around a quarter of tests from the hospital’s microbiology lab have come in positive for the bacteria, which she says is unusually high. 

The hospital has also seen an increase in patients needing to be hospitalized for the bacteria and who are battling a range of conditions — from lung issues to more complicated neurological complications — though they remain a fraction of overall cases.

“We’ve definitely seen more kids on the seriously ill side of the spectrum,” Nayak said. “Likely not because the bacteria has changed, but because our rates overall are just higher.” 

She cautioned that while the recent increase has been unusual, there has not been a lot of data tracking the disease, so comparisons to previous waves of the bacteria have been challenging.

“Our tracking of Mycoplasma infections is suboptimal,” Nayak said. “This is not something that is reportable to health departments. It has not, until relatively recently, been closely tracked.”

A spokesperson for the New York State Department of Health said that it has also tracked a “marked increase” in Mycoplasma pneumoniae based on data from the state’s emergency rooms, compared to previous years. 

While not all pneumonia cases warrant antibiotics, Nayak said testing can be important to give answers for children and their families battling persistent or serious pneumonia cases, as well as to help make decisions about how to treat the infections.

“The amoxicillin your child is getting because they might have an ear infection, or you think you’re treating another community-acquired pneumonia, those antibiotics will not be effective against Mycoplasma,” Nayak said.